Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)

NCT07403630 is registered in ClinicalTrials.gov with Azienda Ospedaliero-Universitaria di Parma as lead sponsor.

NCT NCT07403630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07403630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)
Lead sponsor
Azienda Ospedaliero-Universitaria di Parma
Phase
Not applicable
Overall status
Recruiting
Start date
May 31, 2023
Completion date
February 12, 2028
Enrollment
300 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia, bladder cancer, chronic leukemia, melanoma, multiple myeloma, myelodysplastic disorders, myeloproliferative disorders, ovarian cancer, pancreatic cancer, pediatric acute lymphoblastic leukemia, pleural mesothelioma, squamous cell carcinoma